Next Article in Journal
Advances and Challenges in Wearable Glaucoma Diagnostics and Therapeutics
Next Article in Special Issue
Validation of a New and Straightforward Algorithm to Evaluate Signal Quality during ECG Monitoring with Wearable Devices Used in a Clinical Setting
Previous Article in Journal
Evaluation of 3D Markerless Motion Capture System Accuracy during Skate Skiing on a Treadmill
 
 
Article
Peer-Review Record

A Portable, Neurostimulation-Integrated, Force Measurement Platform for the Clinical Assessment of Plantarflexor Central Drive

Bioengineering 2024, 11(2), 137; https://doi.org/10.3390/bioengineering11020137
by Ashley N. Collimore 1,†, Jonathan T. Alvarez 2,†, David A. Sherman 2,3, Lucas F. Gerez 2, Noah Barrow 1, Dabin K. Choe 2, Stuart Binder-Macleod 4, Conor J. Walsh 2 and Louis N. Awad 1,*
Reviewer 2: Anonymous
Reviewer 3: Anonymous
Bioengineering 2024, 11(2), 137; https://doi.org/10.3390/bioengineering11020137
Submission received: 5 December 2023 / Revised: 15 January 2024 / Accepted: 26 January 2024 / Published: 30 January 2024
(This article belongs to the Special Issue Addressing Health Disparities with Accessible Sensors and Diagnostics)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

The study is worthy. The developed device is potentially useful for post-troke functional assessment. At this respect, it would be welcome to discuss what are the potential benefits of using CEDRS with respect conventional dynamometers.

The materials and methods are very difficult to follow as the description of the two experiments are splitted in Procedures, Data Proccessing and Statistical Analysis. It would be more useful to describe all these aspects for experiment #1 and then for experiment # 2.

It would be very welcome to start the description of each of the experiments with the purpose of the experiment.

Lines 184-185, declare that the electrodes are for FES.

Line 191: What does this figure has in common with burst superimposition?

Lines 190-197: Very hard to follow. To this reviewer the procedure is more or less as follows, but not 100% sure (please clarify):

1- Muscle potentiation (how it is performed?)

2 - Selection of optimum pulse width.

2.1 - Twitch stimulations with the muscles at rest

2.2- Measurement of the twitch response (how it is done?).

2.3 - Selection of the pulse width: The minimum pulse width generating the largest twitch response.

3 - Ask the participant to perform maximum plantarflexion torque.

4 - Activate FES while a visual steady state has achieved in the plantarflexion torque with the optimal pulse width.

Has pulse duration been optimized for post-stroke participants?

It is not 100% clear for this reviewer the role of the FES beyond defining the MFGA.

Lines 190-198: In which device is selected the optimal pulse with? (CEDRS or dynamometer?)

Lines 273-274: First comment to central drive tests (prior to description?)

Line 280: 6MWT is in "Data Processing" and should be in "Study Procedures"

Line 283: Not sure what it is the "distance-induced change in xis-minute walk test speed"

Lines 352-353: Confidence intervals for the coefficients of the equation would be welcome and can be obtained from the leave-one-out method.

Lines 392-...: I don't understand what is "Combining the two participants without 6MWT, etc...)

Figure 4C and Figure 4D: Whats the meaning of "100 = Full Activation"?

 

Author Response

Please see attachement

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

Very well written manuscript

Only one comment, L 39 - would use () to go around your i.e.,

You do that in other instances in the paper

Author Response

Please see attachment.

Author Response File: Author Response.pdf

Reviewer 3 Report

Comments and Suggestions for Authors

Review of work:

''A portable, neurostimulation-integrated, force measurement platform for the clinical assessment of plantarflexor central drive''

1.The  Materials and Methods need considerable improvement. Firstly, please switch the order. Information about patients, recruitment etc. should come before the research tool.

2.Figure 1. - Remove outer black frame.

3.Justify sample size - add sample size calculations.

4.L175 – ‘’ no known neurological impairments’’. How has this been verified? Specify what you mean by '' impairments''. A description of the exact exclusion criteria is missing. The authors are investigating a plantarflexor force and central drive measurement system.

5.The text shows that the group was not heterogeneous. Why did the authors choose to study such a small group not heterogeneously?

6.There is a lack of statistical comparison of numbers, age, BMI and dominant side between groups. Please add.

7.L313 – ‘’ as small (≥0.2), medium (≥0.5), or large (≥0.8) effects’’ - These are the quantities assumed for Cohen's d for eta square are different. This is a factual error.

It should be ‘’ as small (≥0.01), medium (≥0.06), or large (≥0.14) effects’’

8.The conclusions are too much a repetition of the results and discussions. Please rephrase.

Kind Regards

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Back to TopTop